Compare MCD & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCD | TMO |
|---|---|---|
| Founded | 1940 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.6B | 216.4B |
| IPO Year | N/A | N/A |
| Metric | MCD | TMO |
|---|---|---|
| Price | $309.13 | $623.99 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 19 |
| Target Price | $328.30 | ★ $637.78 |
| AVG Volume (30 Days) | ★ 2.8M | 2.1M |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.43% | 0.27% |
| EPS Growth | 2.90 | ★ 8.54 |
| EPS | 11.72 | ★ 17.32 |
| Revenue | $26,264,000,000.00 | ★ $43,736,000,000.00 |
| Revenue This Year | $3.94 | $4.33 |
| Revenue Next Year | $5.65 | $5.05 |
| P/E Ratio | ★ $26.11 | $36.93 |
| Revenue Growth | 1.25 | ★ 3.22 |
| 52 Week Low | $280.41 | $385.46 |
| 52 Week High | $326.32 | $643.99 |
| Indicator | MCD | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 59.26 |
| Support Level | $302.45 | $606.00 |
| Resistance Level | $311.18 | $643.99 |
| Average True Range (ATR) | 4.12 | 16.44 |
| MACD | 0.06 | 1.32 |
| Stochastic Oscillator | 83.54 | 61.14 |
McDonald's is the world's largest restaurant brand, with nearly $131 billion in systemwide sales across more than 44,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 61%), with the remainder stemming from company-operated restaurants across three segments: the United States (41% of systemwide sales), international operated markets (34%), and international developmental/licensed markets (25%).
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).